CellCOM
Hospital del Mar
Barcelona, EspañaPublicacións en colaboración con investigadores/as de Hospital del Mar (8)
2024
-
Melanoma Registry of the Spanish Academy of Dermatology and Venereology (REGESMEL): Description and Data in its First Year of Operation
Actas Dermo-Sifiliograficas, Vol. 115, Núm. 7, pp. 663-669
2021
-
Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study
European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382
2019
-
Breast implant-associated anaplastic large-cell lymphoma. Consensus document part II: Staging, prognosis and follow-up
Revista de Senologia y Patologia Mamaria, Vol. 32, Núm. 2, pp. 67-74
-
Breast-implant associated anaplastic large-cell lymphoma. Consensus document (I). Epidemiology, pathogenesis, symptoms and diagnosis
Revista de Senologia y Patologia Mamaria, Vol. 32, Núm. 2, pp. 61-66
2016
-
Urine metabolome profiling of immune-mediated inflammatory diseases
BMC Medicine, Vol. 14, Núm. 1
2011
-
Clinical characteristics and disease course in patients treated with efalizumab following suspension of marketing authorization by the European Medicines Agency: A multicenter observational study
Actas Dermo-Sifiliograficas, Vol. 102, Núm. 5, pp. 354-364
2001
-
Azelastine tablets in the treatment of chronic idiopathic urticaria: Phase III, randomised, double-blind, placebo and active controlled multicentric clinical trial
Skin Pharmacology and Applied Skin Physiology, Vol. 14, Núm. 2, pp. 77-86
1995
-
Erythromycin lauryl sulphate in combination with tretinoin in the topical treatment of acne vulgaris. A multicentre double-blind clinical trial
Journal of Dermatological Treatment, Vol. 6, Núm. 1, pp. 47-50